Companies / Veradermics, Inc / Activity
Activity — Veradermics, Inc
76 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Childs John W Director | Other | Common Stock | — | +521K +37.54% | 1,907,889 4.57% of shares | low |
| Feb 5, 2026 | Childs John W Director | Other | Common Stock | — | +907K +188.82% | 1,387,131 3.32% of shares | low |
| Feb 5, 2026 | Childs John W Director | Other | Common Stock | — | +480K | 480,269 1.15% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Series C Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Series C Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Series B Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Common Stock | — | +1.2M | 1,171,121 2.80% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Common Stock | — | +1.2M +94.70% | 2,407,752 5.76% of shares | low |
| Feb 5, 2026 | Longitude Capital Partners V, LLC 10% owner | Other | Common Stock | — | +1.2M | 1,236,631 2.96% of shares | low |
| Feb 3, 2026 | Enright Patrick G Director | Grant | Stock Option (Right to Buy) | — | +45K | 45,131 0.11% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Series C Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Series C Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Series B Convertible Preferred Stock | — | -1.2M -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Common Stock | — | +1.2M | 1,171,121 2.80% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Common Stock | — | +1.2M +94.70% | 2,407,752 5.76% of shares | low |
| Feb 5, 2026 | Enright Patrick G Director | Other | Common Stock | — | +1.2M | 1,236,631 2.96% of shares | low |
| Feb 3, 2026 | Greco Michael V. Executive | Grant | Stock Option (Right to Buy) | — | +144K | 144,401 0.35% of shares | low |
| Feb 3, 2026 | Neumann Mark Executive | Grant | Stock Option (Right to Buy) | — | +103K | 102,885 0.25% of shares | low |
| Feb 3, 2026 | Carrano Dominic Gabriel Executive | Grant | Stock Option (Right to Buy) | — | +148K | 148,011 0.35% of shares | low |
| Feb 3, 2026 | Durso Timothy August Executive | Grant | Stock Option (Right to Buy) | — | +213K | 213,352 0.51% of shares | low |
| Feb 5, 2026 | Durso Timothy August Executive | Other | Series A Convertible Preferred Stock | — | -1K -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Durso Timothy August Executive | Other | Common Stock | — | +1K +1.26% | 118,190 0.28% of shares | low |
| Feb 3, 2026 | Waldman Reid Alexander CEO | Grant | Stock Option (Right to Buy) | — | +556K | 556,399 1.33% of shares | low |
| Feb 5, 2026 | Waldman Reid Alexander CEO | Other | Series A Convertible Preferred Stock | — | -1K -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Waldman Reid Alexander CEO | Other | Common Stock | — | +1K +0.62% | 234,872 0.56% of shares | low |
| Feb 3, 2026 | Pance Katarina Director | Grant | Stock Option (Right to Buy) | — | +43K | 43,000 0.10% of shares | low |